Synairgen Share Discussion Threads

[ambyth] 21/7/2020 22:39

We will quickly license, or partner with one, or many, of Pfizer, Roche, Novartis, Merck, GSK, J&J, Abbvie, Sanofi, AZ, or, of course, be simply taken over.

This is absolutely huge: Hold and Add.

IMHO-DYOR.

[yet another final] 21/7/2020 22:31

One global deal preferable

[yet another final] 21/7/2020 22:28

Larger trial not necessary if data is correct and peer reviewed, as mentioned earlier by another posterEnough to be approved as Class 1B indication, and approved by NICE as I mentioned earlier today, especially as the data implies cost effectiveness (cheaper than a kidney transplant which used to be the standard for cost effectiveness) I trust the research team at Southampton, and they will not be cutting any corners as this would have a devastating impact on their longterm credibility...

[nobbygnome] 21/7/2020 22:22

If it was AZ I suspect it would be a global deal, although not impossible it could be licensed market by market. One global deal is the most likely though...or a takeover of course!

[yet another final] 21/7/2020 22:21

Would not be surprised if they raise funds by means of a placing, but to go it alone, they will need chunks... All depends on potential collaboration with big pharma.... AZ call us.!

[zen12] 21/7/2020 22:21

Second that....results amazing and life saving! But what do us Brits do best...we look for all sorts of ways to batter it down! It's surely in terms of all the drugs phase 2 tested for COVID19, the best drug...fullstop!

[ambyth] 21/7/2020 22:20

Trump has realised his poll numbers, and so any chances of election success, are tied inextricably to the Pandemic, or as he repeatedly calls it “The China virus”, and is resuming daily briefings, signalling a major shift in direction from today:

"Masks", "Treatments", "Vaccines", "Working with other countries" etc.

Talking about new treatments coming out etc. now:

He looks and sounds desperate now, and needs something; as SNG news bleeds to him he will of course grab it.

[daveboy1] 21/7/2020 22:15

And which mm are you working for, Millie just out of interest... lol.

[yet another final] 21/7/2020 22:15

If SNG was American, the results would be trumpeted at every chance, and already be valued at over 1bnBut here in the UK we build em up to knock them down....The results are amazing... Better than expected, given the small recruitment numbers. So rather than looking on the negative side of very little, let's see the positive 'elephant in the room'I had my concerns about the number of subjects, and despite this the results were clear cut.IT worksIt's safe, given previous data from other trialsIt prevents deterioration of Covid infection, and the need for ventilationIt is needed, cos even with a vaccine, people will still get infectedAZ know the senior team at SNG so I guess date night is on for both ceo'sExpect some major tie up with AZ, with us holding all the chips...Also expect tie with major US pharmaceutical Co? PfizerExciting times and patience is needed... As well as a good calculator for all the number crunching (I'll accept a Str8 takeover valuing is at 1 bn soon)

[allin] 21/7/2020 22:10

A bigger trial is needed. It is encouraging though. This was only a prelim announcement and share price level reflect as such. Agree the price could go ballastic IF the treatment is viable. Signs are encouraging.